China Pharmaceutical Glass Packaging Market, By Material (Type I, Type II, Type III), Product (Bottles, Ampoules, Cartridges and Syringes, Vials and Others), Drug Type (Generic, Branded, Biologic), Application (Oral, Injectable, Nasal, Others), End-Use (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Development, and Manufacturing Companies, Compound Pharmacy, Others), Market Trends and Forecast to 2028.
Market Analysis and Insights: China Pharmaceutical Glass Packaging Market
China pharmaceutical glass packaging market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing at a CAGR of 7.8% in the forecast period of 2021 to 2028 and is expected to reach USD 644,097.16 thousand by 2028.
It is increasing health awareness and adopting new techniques for storing liquid drugs that drive the market. The increasing cost of overall drug packaging acts as a restraint to the market. The growing demand for ready-to-use glass vials plays as an opportunity for pharmaceutical glass packaging manufacturing. The increasing stringent government regulations relating to pharmaceutical glass packaging can be a challenge for the manufacturers.
This pharmaceutical glass packaging market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.
China Pharmaceutical Glass Packaging Market Scope and Market Size
The pharmaceutical glass packaging market is segmented based on material, product, drug type, application, and end-use. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of material, the market is segmented into Type I, Type II, and Type III. In China, Type I is dominating because of the growing usage in drug formulations storage methods, which has widened its consumption.
- On the basis of product, the market is segmented into bottles, ampoules, cartridges and syringes, vials, and others. In China, the bottles segment is dominating because of the increasing demand for airtight properties of products.
- On the basis of drug type, the market is segmented into generic, branded, and biologic. In China, generic is dominating because of growing usage among young and old age groups.
- On the basis of application, the market is segmented into nasal, oral, injectable, and others. In China, oral is dominating because of the increasing consumption of products among the end-users.
- On the basis of end-user, the market is segmented into pharmaceutical companies, biopharmaceutical companies, contract development and manufacturing companies, compound pharmacy, and others. In China, pharmaceutical companies are expected to dominate the market because of the increasing growth of the sector due to the ongoing pandemic situation.
Pharmaceutical Glass Packaging Market Country Level Analysis
The pharmaceutical glass packaging market is segmented based on material, product, drug type, application, and end-use.
China pharmaceutical glass packaging market is dominating the market due to the growing demand for packaging in the pharmaceutical industry in the region.
China Pharmaceutical Glass Packaging Market, By Drug Type
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of China brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Growth in the Pharmaceutical Glass Packaging Industry during the Pandemic
China pharmaceutical glass packaging market also provides you with detailed market analysis for every country growth in the installed base of different kinds of products for the pharmaceutical glass packaging market, impact of technology using lifeline curves and changes in infant formula regulatory scenarios, and their impact on the pharmaceutical glass packaging market. The data is available for the historical period 2010 to 2019.
Competitive Landscape and Pharmaceutical Glass Packaging Market Share Analysis
China pharmaceutical glass packaging market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to China pharmaceutical glass packaging market.
The major players covered in the report are NIPRO, Gerresheimer AG, SGD Pharma (a subsidiary of Saint-Gobain), Shandong Province Medicinal Glass Co., Ltd., Bormioli Pharma S.p.a., Taian Youlyy Industrial Co., Ltd., SCHOTT AG, FRIGOGLASS, among other players domestic and global. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
For instance,
- In 2020, Shandong Province Medicinal Glass Co., Ltd. was named the 3rd of the top 10 enterprises for the daily usage of the glass industry in the China Light industry. The update helped the company to increase the customer base, which generates revenue for the company
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF CHINA PHARMACEUTICAL GLASS PACKAGING MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MATERIAL TYPE LIFE LINE CURVE
2.7 MULTIVARIATE MODELLING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 DBMR MARKET CHALLENGE MATRIX
2.12 IMPORT-EXPORT DATA
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CHINA:
4.2 MIDDLE EAST AND AFRICA:-
4.3 INDIA:
4.4 RUSSIA:
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 EXTENSIVE UTILIZATION OF GENERIC INJECTABLE DRUGS
5.1.2 GROWING ENVIRONMENTAL CONCERNS ASSOCIATED WITH PLASTIC PACKAGING
5.1.3 INCREASING HEALTH AWARENESS AND ADOPTION OF NEW TECHNIQUES FOR STORAGE OF LIQUID DRUGS
5.2 RESTRAINTS
5.2.1 CHEMICAL RELEASE FROM THE INTERNAL SURFACE OF GLASS CONTAINERS
5.2.2 INCREASING COST OF OVERALL DRUG PACKAGING AND HANDLING
5.3 OPPORTUNITIES
5.3.1 GROWING DEMAND FOR READY-TO-USE GLASS VIALS FOR FLEXIBLE ASEPTIC FILLING
5.3.2 INCREASING DEMAND FOR THE PHARMACEUTICAL GLASS PACKAGING DURING PANDEMIC
5.4 CHALLENGE
5.4.1 STRINGENT GOVERNMENT REGULATIONS RELATING TO THE PHARMACEUTICAL INDUSTRY
6 IMPACT OF COVID-19 ON THE CHINA PHARMACEUTICAL GLASS PACKAGING MARKET
6.1 AFTERMATH OF COVID-19 AND GOVERNMENT INITIATIVE TO BOOST THE CHINA PHARMACEUTICAL GLASS PACKAGING MARKET
6.2 STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
6.3 PRICE IMPACT
6.4 IMPACT ON DEMAND
6.5 IMPACT ON SUPPLY CHAIN
6.6 CONCLUSION
7 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL
7.1 OVERVIEW
7.2 TYPE I
7.3 TYPE II
7.4 TYPE III
8 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 BOTTLES
8.2.1 SMALL BOTTLES
8.2.2 LARGE BOTTLES
8.3 AMPOULES
8.4 CARTRIDGES & SYRINGES
8.5 VIALS
8.5.1 VIALS BY CAP SIZE
8.5.1.1-400 MM
8.5.1.2-425 MM
8.5.1.3-425MM
8.5.1.4-350 MM
8.5.1.5-400MM
8.5.1.6 8-425MM
8.5.1.7 9MM
8.5.1.8 OTHERS
8.5.2 VIALS BY CAPACITY
8.5.2.1 ML
8.5.2.2 8ML
8.5.2.3 4 ML
8.5.2.4 3 ML
8.5.2.5 2 ML
8.5.2.6 1 ML
8.5.2.7 ML
8.5.2.8 ML
8.5.2.9 ML
8.5.2.10 OTHERS
8.6 OTHERS
9 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY DRUG TYPE
9.1 OVERVIEW
9.2 GENERIC
9.3 BRANDED
9.4 BIOLOGIC
10 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 ORAL
10.3 INJECTABLE
10.4 NASAL
10.5 OTHERS
11 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY END-USE
11.1 OVERVIEW
11.2 PHARMACEUTICAL COMPANIES
11.3 BIOPHARMACEUTICAL COMPANIES
11.4 CONTRACT DEVELOPMENT AND MANUFACTURING COMPANIES
11.5 COMPOUND PHARMACY
11.6 OTHERS
12 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY REGION
12.1 CHINA
13 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: CHINA PHARMACEUTICAL GLASS PACKAGING MARKET
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 WEST PHARMACEUTICAL SERVICES, INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT UPDATE
15.2 CORNING INCORPORATED
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT UPDATES
15.3 GERRESHEIMER AG
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT UPDATE
15.4 NIPRO
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT UPDATE
15.5 FRIGOGLASS
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT UPDATE
15.6 SGD PHARMA (A SUBSIDIARY OF SAINT-GOBAIN)
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT UPDATE
15.7 MIDDLE EAST GLASS - MEG
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT UPDATE
15.8 HINDUSTAN NATIONAL GLASS & INDUSTRIES LIMITED.
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT UPDATE
15.9 SCHOTT AG
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT UPDATE
15.1 APG
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT UPDATE
15.11 BORMIOLI PHARMA S.P.A.
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT UPDATE
15.12 RAK GHANI GLASS LLC
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT UPDATE
15.13 SHANDONG PROVINCE MEDICINAL GLASS CO., LTD.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT UPDATE
15.14 TAIAN YOULYY INDUSTRIAL CO., LTD.
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT UPDATE
16 QUESTIONNAIRE
17 RELATED REPORTS
Список таблиц
TABLE 1 IMPORT DATA OF PRODUCT: 7010 CARBOYS, BOTTLES, FLASKS, JARS, POTS, PHIALS, AMPOULES AND OTHER CONTAINERS, OF GLASS, OF A.....HS CODE: 7010 (USD THOUSAND)
TABLE 2 EXPORT DATA OF PRODUCT: 7010 CARBOYS, BOTTLES, FLASKS, JARS, POTS, PHIALS, AMPOULES AND OTHER CONTAINERS, OF GLASS, OF A.....HS CODE: 7010 (USD THOUSAND)
TABLE 3 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL, 2019-2028 (USD THOUSAND)
TABLE 4 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL, 2019-2028 (THOUSAND UNITS)
TABLE 5 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 6 CHINA BOTTLES IN PHARMACEUTICAL GLASS PACKAGING MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 7 CHINA VIALS IN PHARMACEUTICAL GLASS PACKAGING MARKET, BY CAP SIZE, 2019-2028 (USD THOUSAND)
TABLE 8 CHINA VIALS IN PHARMACEUTICAL GLASS PACKAGING MARKET, BY CAPACITY, 2019-2028 (USD THOUSAND)
TABLE 9 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)
TABLE 10 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 11 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY END-USE, 2019-2028 (USD THOUSAND)
TABLE 12 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL, 2019-2028 (USD THOUSAND)
TABLE 13 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL, 2019-2028 (THOUSAND UNITS)
TABLE 14 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 15 CHINA BOTTLES IN PHARMACEUTICAL GLASS PACKAGING MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 16 CHINA VIALS IN PHARMACEUTICAL GLASS PACKAGING MARKET, BY CAP SIZE, 2019-2028 (USD THOUSAND)
TABLE 17 CHINA VIALS IN PHARMACEUTICAL GLASS PACKAGING MARKET, BY CAPACITY, 2019-2028 (USD THOUSAND)
TABLE 18 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)
TABLE 19 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 20 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY END-USE, 2019-2028 (USD THOUSAND)
Список рисунков
FIGURE 1 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: SEGMENTATION
FIGURE 2 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: DATA TRIANGULATION
FIGURE 3 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: DROC ANALYSIS
FIGURE 4 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: CHINA VS REGIONAL MARKET ANALYSIS
FIGURE 5 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: MATERIAL LIFE LINE CURVE
FIGURE 7 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 11 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: SEGMENTATION
FIGURE 12 INCREASING HEALTH AWARENESS AND ADOPTION OF NEW TECHNIQUES FOR THE STORAGE OF LIQUID DRUGS IS DRIVING THE CHINA PHARMACEUTICAL GLASS PACKAGING MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 TYPE I IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE CHINA PHARMACEUTICAL GLASS PACKAGING MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE OF CHINA PHARMACEUTICAL GLASS PACKAGING MARKET
FIGURE 15 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL, 2020
FIGURE 16 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: BY PRODUCT, 2020
FIGURE 17 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: BY DRUG TYPE, 2020
FIGURE 18 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY APPLICATION, 2020
FIGURE 19 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY END-USE, 2020
FIGURE 20 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: COMPANY SHARE 2020 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
